As of 2026-04-08, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 24.3x | 11.8x |
| Forward P/E multiples | 16.4x - 35.3x | 25.3x |
| Fair Price | (141.64) - (211.48) | (161.00) |
| Upside | -241.7% - -311.5% | -261.0% |
| Date | EV/EBITDA |